As of 2024, the AAOS Clinical Practice Guidelines (CPG) updated the evidence rating for bioinductive and bioconductive augmentation in rotator cuff repairs to ”Moderate” or “Strong.” This reflects an industry shift from mechanical fixation to biological integration.  Data from…

The Electrospinning Company was pleased to welcome representatives from DSM for a recent visit to our facilities.  The visit provided an opportunity to reinforce the long-standing relationship between our organisations and to…

The Electrospinning Company recently participated in MD&M West 2026 in Anaheim, one of the world’s leading events for medical device innovation and manufacturing. Our discussions with device manufacturers, R&D leaders, and innovation teams revealed…

The Electrospinning Company, a leading innovator in nanofibrous biomaterials for medical devices, has announced a strategic partnership with Avem Market Solutions to bring its advanced products to a broader range…

The Electrospinning Company and Bioinicia Fluidnatek collaborate to provide the medical device industry with unmatched levels of process development and manufacturing capability for electrospun materials and implantable devices. ELECTROSPINNING uses…

Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth    Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in…